United States

Back to map

Showing 11-20 of 56 grants

Title Institution Researcher Program Duration Total Award Amount
ALIGN-T1D Start-Up Secretariat Clinton Health Access Initiative (CHAI) Colin Brown Mission 01-October-2025 to 31-March-2027 $822,000.00
Changing the T1DE: A randomized controlled trial comparing ACT to supportive diabetes counseling Duke University Rhonda Merwin Improving Lives 01-July-2022 to 30-June-2027 $2,758,224.22
Using genetics to better diagnose and treat adult-onset T1D in multi-ethnic US population Geisinger Clinic David Carey Cures 01-November-2022 to 30-September-2026 $1,469,640.10
Synthetic Hydrogels for Islet Vascularization and Engraftment Georgia Tech Research Corporation Andres Garcia Cures 01-July-2022 to 30-June-2026 $563,235.05
Advanced Oxygen Generator for Oxygenated Cell Capsules Giner, Inc. Linda Tempelman Cures 01-June-2021 to 30-September-2026 $448,173.29
Advanced Preclinical Development of iTOL-101, a Combination Investigational Product Composed of A Biotechnology-Derived Chimeric Streptavidin and A Fas Ligand (SA-FasL) Protein Bound to Biotinylated Hydrogel-Based Microparticles (Microgel) and Mixed with Deceased Donor Human Pancreatic Islets for the Treatment of Poorly-Controlled (or “Brittle”) Type 1 Diabetes iTolerance, Inc. Camillo Ricordi Cures 01-June-2022 to 31-March-2027 $850,000.00
JDRF T1D Coordinating Center Jaeb Center for Health Research Judy Sibayan Transportfolio 01-August-2019 to 31-August-2027 $2,914,531.01
Randomized Clinical Trial Evaluating Fenofibrate for Prevention of Diabetic Retinopathy Worsening Jaeb Center for Health Research Adam Glassman Improving Lives 01-February-2021 to 31-August-2026 $750,000.00
Towards FDA approval of Autonomous AI for diabetic retinopathy screening in youth Johns Hopkins University Risa Wolf Improving Lives 01-January-2023 to 31-December-2026 $637,547.20
Effectiveness and safety of sotagliflozin in slowing kidney function decline in persons with type 1 diabetes and moderate to severe diabetic kidney disease: The SUGARNSALT Trial Joslin Diabetes Center Inc. Alessandro Doria Improving Lives 01-January-2024 to 31-December-2028 $8,913,450.00